Fund Details
Magnetic Ventures
Overview
Investment portfolio
16rounds
| NAME | DATE | SIZE | |
|---|---|---|---|
Proxima | Jan 2026Participated | $80 MSeed | |
Relation Therapeutics | Dec 2025Participated | $26 MOther Equity | |
Weave | Oct 2025Participated | $20 MSeries A | |
trawa | May 2025Participated | $28 MSeries A | |
Terrain Biosciences | Feb 2025Participated | $9 MSeed | |
Weave | May 2024Led | $10 MSeed | |
Relation Therapeutics | Mar 2024Participated | $35 MSeed | |
Paradigm | Jan 2023Participated | $203 MSeries A | |
Transition Bio | Jun 2022Participated | $50 MSeries A | |
Spotlight Therapeutics | Mar 2022Participated | $37 MSeries B | |
Deep Genomics | Aug 2021Participated | $180 MSeries C | |
HiberCell | May 2021Participated | $97 MSeries B | |
Proxima | Jan 2026Participated | $80 MSeed | |
Relation Therapeutics | Dec 2025Participated | $26 MOther Equity | |
Weave | Oct 2025Participated | $20 MSeries A | |
trawa | May 2025Participated | $28 MSeries A | |
Terrain Biosciences | Feb 2025Participated | $9 MSeed | |
Weave | May 2024Led | $10 MSeed | |
Relation Therapeutics | Mar 2024Participated | $35 MSeed | |
Paradigm | Jan 2023Participated | $203 MSeries A | |
Transition Bio | Jun 2022Participated | $50 MSeries A | |
Spotlight Therapeutics | Mar 2022Participated | $37 MSeries B | |
Deep Genomics | Aug 2021Participated | $180 MSeries C | |
HiberCell | May 2021Participated | $97 MSeries B |
16 Items
16
Items
...
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 2 | 4 |
| Series A | 0 | 5 |
| Series B | 1 | 2 |
| Series C+ | 0 | 1 |
| Other Equity | 0 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| May '19 | 1 |
| Jun '19 | 0 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 1 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 1 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 1 |
| Apr '21 | 0 |
| May '21 | 1 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 1 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 1 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 1 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 1 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 1 |
| Apr '24 | 0 |
| May '24 | 1 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 1 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 1 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 1 |
| Nov '25 | 0 |
| Dec '25 | 1 |
| Jan '26 | 1 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 14 |
| AI & Machine Learning | 4 |
| Enterprise Software | 2 |
| Networks, Cloud & Communication | 1 |
| AR/VR | 1 |
| Clean Energy & Sustainability | 1 |
| Data, Analytics & IT | 1 |
| Consumer & Lifestyle | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 2 |
| $5M-$10M | 1 |
| $10M-$25M | 3 |
| $25M-$50M | 5 |
| $50M-$100M | 3 |
| $100M-$250M | 2 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 3 of 3 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 12 |
| Europe | 3 |
| Canada | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Data Collective | 3 |
| NVentures | 3 |
| Alexandria Venture Investments | 2 |
| ARCH Venture Partners | 2 |
| Bristol Myers Squibb | 2 |
| F-Prime Capital | 2 |
| Google Ventures | 2 |
| Innovation Endeavors | 2 |
| Khosla Ventures | 2 |
| 7wireVentures | 1 |
| AENU | 1 |
| AIX Ventures | 1 |
| American Cancer Society | 1 |
| American Heart Association | 1 |
| Amplitude Ventures | 1 |
| ARK Invest | 1 |
| Balderton Capital | 1 |
| Braidwell | 1 |
| Bruker | 1 |
| Canada Pension Plan Investment Board | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 3 | 19% |
| Participating | 13 | 81% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 2 | 67% |
| Co-led | 1 | 33% |
Team
Christine Aylward
Founder & Managing Partner